PCSA
Processa Pharmaceuticals Inc

4,543
Mkt Cap
$14.33M
Volume
663,039.00
52W High
$1.50
52W Low
$0.15
PE Ratio
-0.19
PCSA Fundamentals
Price
$0.2626
Prev Close
$0.253
Open
$0.263
50D MA
$0.2964
Beta
0.78
Avg. Volume
23.08M
EPS (Annual)
-$3.87
P/B
2.38
Rev/Employee
$0.00
Loading...
Loading...
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10

Frequently Asked Questions

What is Market Cap of Processa Pharmaceuticals Inc?
What is the 52-week high for Processa Pharmaceuticals Inc?
What is the 52-week low for Processa Pharmaceuticals Inc?
What is Processa Pharmaceuticals Inc stock price today?
What was Processa Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Processa Pharmaceuticals Inc?
What is the Price-to-Book ratio of Processa Pharmaceuticals Inc?
What is the 50-day moving average of Processa Pharmaceuticals Inc?
How many employess does Processa Pharmaceuticals Inc has?

Latest PCSA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.